Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance

Immunology

Volumn 100, Issue 2, 2000, Pages 217-224

  Szeto, C C ^a   Gillespie, K M ^a   Mathieson, P W ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 4; LEVAMISOLE; MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG MECHANISM; GENE EXPRESSION REGULATION; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTINEMATODAL AGENTS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN E; INTERFERON TYPE II; INTERLEUKIN-18; INTERLEUKIN-4; LEVAMISOLE; MALE; MERCURIC CHLORIDE; RATS; RATS, INBRED BN; TH2 CELLS;

EID: 0034120590     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00042.x     Document Type: Article

References (34)

1. 1. MOSMANN T.R. & COFFMAN R.L. (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7, 145.
2. 2. HAANEN J.B., DE WAALMALEVIJT R., RES P.C. et al. (1991) Selection of a human T helper type 1-like T-cell subset by mycobacteria. J Exp Med 174, 583.
3. 3. BLOOM B.R., MODLIN R.L. & SALGAME P. (1992) Stigma variations: observations on supppressor T cells and leprosy. Annu Rev Immunol 10, 453.
4. 4. HEURTIER A.H. & BOITARD C. (1997) T-cell regulation in murine and human autoimmune diabetes: the role of TH1 and TH2 cells. Diabetes Metab 23, 377.
5. 5. COHEN I.R. (1997) The Th1/Th2 dichotomy, hsp60 autoimmunity, and type I diabetes. Clin Immunol Immunopathol 84, 103.
6. 6. MILTENBURG A.M., VAN LAAR J.M., DE KUIPER R., DAHA M.R. & BREEDVELD F.C. (1992) T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol 35, 603.
7. 7. QUAYLE A.J., CHOMARAI P., MIOSSEC P., KJFLDSEN-KRAGH J., FORRE O. & NATVIG J.B. (1993) Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns. Scand J Immunol 38, 75.
8. 8. VAN DER GRAAFF W.L., PRINS A.P., DIJKMANS B.A. & VAN LIER R.A. (1998) Prognostic value of Th1/Th2 ratio in rheumatoid arthritis. Lancet 351, 1931.
9. 9. RICHAUD-PATIN Y., ALCOCER-VARELA J. & LLORENTF L. (1995) High levels of TH2 cytokine gene expression in systemic lupus erythematosus. Rev Invest Clin 47, 267.
10. 10. FUNAUCHI M., IKOMA S., ENOMOTO H. & HORIUCHI A. (1998) Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus. Scand J Rheumatol 27, 219.
11. 11. ROBINSON D.S., HAMID Q., YING S. et al. (1992) Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326, 298.
12. 12. KAY A.B. (1996) TH2-type cytokines in asthma. Ann NY Acad Sci 796, 1.
13. 13. NICKERSON P., STEURER W., STEIGER J., ZHENG X., STEELE A.W. & STROM T.B. (1994) Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol 6, 757.
14. 14. CARTER L.L. & DUTTON R.W. (1996) Type 1 and type 2: a fundamental dichotomy for all T-cell subsets. Curr Opin Immunol 8, 336.
15. 15. KAR H.K., BHATIA V.N., KUMAR C.H., SIRUMBAN P. & ROY R.G. (1986) Evaluation of levamisole, an immunopotentiator, in the treatment of lepromatous leprosy. Indian J Lepr 58, 592.
16. 16. KATOCII K. (1996) Immunotherapy of leprosy. Indian J Lepr 68, 349.
17. 17. MUTCH R.S. & HUTSON P.R. (1991) Levamisole in the adjuvant treatment of colon cancer. Clin Pharmacol 10, 95.
18. 18. MATHIESON P.W. (1992) Mercuric chloride-induced autoimmunity. Autoimmunity 13, 243.
19. 19. GILLESPIE K.M., SAOUDI A., KUHN J., WHITTLE C.J., DRUFF P. & MATHIESON P.W. (1996) Th1/Th2 cytokine gene expression after mercuric chloride in susceptible and resistant rat strains. Eur J Immunol 26, 2388.
20. 20. USHIO S., NAMBA M., OKURA T. et al. (1996) Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 156, 4274.
21. 21. CHOMCZYNSKI P. & SACCHI N. (1987) Single-step method of RNA isolation by acid guanidium thiocyanate phenol chloroform extraction. Anal Biochem 162, 156.
22. 22. TOURNADE H., PELLETIER L., GUERY J.C. et al. (1991) Experimental gold-induced autoimmunity. Nephrol Dial Transplant 6, 621.
23. 23. GILLESPIE, K.M., QASIM F.J., TIBBATTS L.M., THIRU S., OLIVEIRA D.B.G. & MATHIESON P.W. (1995) Interleukin-4 gene expression in mercury-induced autoimmunity. Scand J Immunol 41, 268.
24. 1 T cells. Eur J Immunol 21, 1187.
25. 25. MATHIESON P.W. & GILLESPIE K.M. (1996) Cloning of a partial cDNA for rat interleukin 12(IL12) and analysis of IL12 expression in vivo. Scand J Immunol 44, 11.
26. 26. CONTI B., JAHNG J.W., TINTI C., SON J.H. & JOH T.H. (1997) Induction of interferon-γ inducing factor in the adrenal cortex. J Biol Chem 272, 2035.
27. 27. MICALLEF M.J., OHTSUKI T., KOHNO K. et al. (1996) Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol 26, 1647.
28. 28. YOSHIMOTO, T., OKAMURA H., TAGAWA Y.I., IWAKURA Y. & NAKANISHI K. (1997) Interleukin 18 together with interleukin 12 inhihits IgE production by induction of interferon-gamma production from activated B cells. Proc Natl Acad Sci USA 94, 3948.
29. 29. British Association for Pediatric Nephrology (1991) Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. Lancet 337, 1555.
30. 30. DAYAL U., DAYAL A.K., SHASTRY J.C.M. & RAGHUPATHY P. (1994) Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children. Nephron 66, 408.
31. 31. SCHULTE-WISSERMANN H., GORTZ W. & STRAUB E. (1979) IgE in patients with glomerulonephritis and minimal-change nephrotic syndrome. Eur J Pediatr 131, 105.
32. 32. MEADOW S.R. & SARSFIELD J.K. (1981) Steroid-responsive nephrotic syndrome and allergy: clinical studies. Arch Dis Child 56, 509.
33. 33. LAM C.N. & ARNEIL G.C. (1968) Long term dwarfing effects of corticosteroid treatment for childhood nephrosis. Arch Dis Child 43, 589.
34. 34. KIMAYE S.R., PILLAI S. & TINA L.U. (1988) Relationship of steroid dose to degree of posterior subcapsular cataracts in nephrotic syndrome. Ann Ophthalmol 20, 225.